DOUGLAS M. HUNT - 02 Jul 2021 Form 4 Insider Report for PUMA BIOTECHNOLOGY, INC. (PBYI)

Role: The Reporting Person is the Senior Vice President of Regulatory Affairs of the Issuer.
Signature: /s/ Douglas M. Hunt
Issuer symbol: PBYI
Transactions as of: 02 Jul 2021
Net transactions value: -$9,298
Form type: 4
Filing time: 06 Jul 2021, 17:40:48 UTC
Previous filing: 04 Jun 2021
Next filing: 03 Aug 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PBYI	COMMON STOCK	Sale	$9,298	-1,016	-1.5%	$9.15	66,943	02 Jul 2021	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sales reported in this Form 4 were to satisfy tax obligations in connection with the vesting of restricted stock units.
F2	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.14 to $9.17, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Content

The sales reported in this Form 4 were to satisfy tax obligations in connection with the vesting of restricted stock units.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.14 to $9.17, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Remarks:

The Reporting Person is the Senior Vice President of Regulatory Affairs of the Issuer.